Moreover, during the recovery period of 6–12 months after surgery, a variety of treatments for breast cancer using chemotherapy can induce metabolic changes, including decreased lean body mass and muscle strength, and a subsequent increase in body weight [18] and insulin resistance [19], which in turn may be associated with increased mortality among patients with breast cancer [17, 19]. This evidence concerns the gene INS and breast cancer.